30 Sept 2026, 09:49
Company UpdateMS
MYXMAYNE PHARMA GROUP LIMITED
Announcement history available from 1 August 2025
Fromto
28 Sept 2026, 09:45
Company Administration—
28 Sept 2026, 09:42
Meetings & Governance—
15 Sept 2026, 09:50
Company Update—
8 Sept 2026, 18:42
Securities Administration—
8 Sept 2026, 18:41
Securities Administration—
28 Aug 2026, 17:29
Securities Administration—
27 Aug 2026, 08:44
Financial Results—
27 Aug 2026, 08:43
Company Administration—
27 Aug 2026, 08:42
Financial ResultsMS
27 Aug 2026, 08:40
Financial ResultsMS
21 Aug 2026, 12:56
Presentations—
20 Aug 2026, 08:59
Company Update—
18 Aug 2026, 09:16
Company Administration—
14 Aug 2026, 17:13
Director Interests—
5 Aug 2026, 17:20
Presentations—
5 Aug 2026, 17:14
Securities Administration—
5 Aug 2026, 17:14
Securities Administration—
5 Aug 2026, 13:35
Company Administration—
3 Aug 2026, 15:46
Company Administration—
31 July 2026, 09:29
Periodic ReportsMS
17 July 2026, 08:53
Company Administration—
7 July 2026, 08:16
Securities Administration—
7 July 2026, 08:16
Securities Administration—
7 July 2026, 08:16
Securities Administration—
7 July 2026, 08:16
Securities Administration—
1 July 2026, 09:38
Director Interests—
26 June 2026, 09:15
Company Administration—
26 June 2026, 09:11
Substantial Holders—
18 June 2026, 14:57
Substantial Holders—
5 June 2026, 15:51
Director Interests—
5 June 2026, 10:44
Periodic ReportsMS
4 June 2026, 17:17
Presentations—
1 June 2026, 08:50
Company Update—
27 May 2026, 08:44
Company Administration—
22 May 2026, 11:08
Company AdministrationMS
18 May 2026, 08:57
Company Update—
7 May 2026, 09:14
Presentations—
4 May 2026, 17:25
Securities Administration—
30 Apr 2026, 08:22
Company Administration—
29 Apr 2026, 09:33
Periodic ReportsMS
7 Apr 2026, 09:41
Company Administration—
2 Apr 2026, 12:33
Company Administration—
31 Mar 2026, 16:38
Substantial Holders—
27 Mar 2026, 16:46
Substantial Holders—
25 Mar 2026, 11:12
Presentations—
24 Mar 2026, 17:32
Substantial Holders—
23 Mar 2026, 16:45
Substantial Holders—
17 Mar 2026, 09:00
Presentations—
11 Mar 2026, 09:22
Presentations—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 30 Sept 2026, 09:49 | MYX settles US patent litigation re Imvexxy with Sun Pharma | Company Update | MS | 11001, 14003 | |
| 28 Sept 2026, 09:45 | Mayne Pharma announces legal settlement | Company Administration | — | 12008, 14003 | |
| 28 Sept 2026, 09:42 | Date for Annual General Meeting | Meetings & Governance | — | 08006 | |
| 15 Sept 2026, 09:50 | MYX signs licence agreement for Blissel in Australia | Company Update | — | 11001 | |
| 8 Sept 2026, 18:42 | Notification of cessation of securities - MYX | Securities Administration | — | 06027 | |
| 8 Sept 2026, 18:41 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 28 Aug 2026, 17:29 | Application for quotation of securities - MYX | Securities Administration | — | 06020 | |
| 27 Aug 2026, 08:44 | 2026 Full Year Results Investor Presentation | Financial Results | — | 03003, 03026 | |
| 27 Aug 2026, 08:43 | 2026 Corporate Governance Statement and Appendix 4G | Company Administration | — | 03024, 03025 | |
| 27 Aug 2026, 08:42 | 2026 Full Year Results Media Release | Financial Results | MS | 03003, 14014 | |
| 27 Aug 2026, 08:40 | 2026 Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 21 Aug 2026, 12:56 | Notification of date for release of FY26 results | Presentations | — | 03027, 14014 | |
| 20 Aug 2026, 08:59 | Upcoming presentation of Imvexxy clinical data | Company Update | — | 11001 | |
| 18 Aug 2026, 09:16 | Mayne Pharma launches Investor Hub | Company Administration | — | 12008 | |
| 14 Aug 2026, 17:13 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 5 Aug 2026, 17:20 | Mayne Pharma Bioshares Summit Presentation | Presentations | — | 03026 | |
| 5 Aug 2026, 17:14 | Notification of cessation of securities - MYX | Securities Administration | — | 06027 | |
| 5 Aug 2026, 17:14 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 5 Aug 2026, 13:35 | Non-Executive Director appointment | Company Administration | — | 12001 | |
| 3 Aug 2026, 15:46 | Mayne Pharma to present at the 20th Bioshares Summit | Company Administration | — | 12008 | |
| 31 July 2026, 09:29 | Mayne Pharma reports unaudited Q4 and FY26 results | Periodic Reports | MS | 03014, 03027, 03028 | |
| 17 July 2026, 08:53 | Mayne Pharma appoints new Chief Financial Officer | Company Administration | — | 12008 | |
| 7 July 2026, 08:16 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 7 July 2026, 08:16 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 7 July 2026, 08:16 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 7 July 2026, 08:16 | Notification regarding unquoted securities - MYX | Securities Administration | — | 06021 | |
| 1 July 2026, 09:38 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 26 June 2026, 09:15 | Mayne Pharma appoints new Non-Executive Director | Company Administration | — | 12001 | |
| 26 June 2026, 09:11 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 18 June 2026, 14:57 | Change in substantial holding | Substantial Holders | — | 02002 | |
| 5 June 2026, 15:51 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 5 June 2026, 10:44 | Mayne Pharma receives $14.4m for legal costs from Cosette | Periodic Reports | MS | 03014, 14003 | |
| 4 June 2026, 17:17 | MYX Jefferies Global Healthcare Conference Presentation | Presentations | — | 03026 | |
| 1 June 2026, 08:50 | New DistributeRx partnership with Resilia Pharmaceuticals | Company Update | — | 11001 | |
| 27 May 2026, 08:44 | Mayne Pharma to present at Jefferies Healthcare Conference | Company Administration | — | 12008 | |
| 22 May 2026, 11:08 | Court awards MYX $13.27m for legal costs from Cosette | Company Administration | MS | 14003 | |
| 18 May 2026, 08:57 | Mayne Pharma announces expansion of Adelaide Apothecary | Company Update | — | 11001 | |
| 7 May 2026, 09:14 | Mayne Pharma 3Q investor presentation | Presentations | — | 03026 | |
| 4 May 2026, 17:25 | Notification of cessation of securities - MYX | Securities Administration | — | 06027 | |
| 30 Apr 2026, 08:22 | Further details re equity instruments to be issued to CEO | Company Administration | — | 06009, 12008 | |
| 29 Apr 2026, 09:33 | Mayne Pharma reports unaudited 3Q FY26 results | Periodic Reports | MS | 03014 | |
| 7 Apr 2026, 09:41 | MYX expects no material impact from US s232 tariffs | Company Administration | — | 12008 | |
| 2 Apr 2026, 12:33 | Non-Executive Director retirement and recruitment | Company Administration | — | 12001 | |
| 31 Mar 2026, 16:38 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 27 Mar 2026, 16:46 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 25 Mar 2026, 11:12 | Mayne Pharma ASX SMIDcaps conference presentation | Presentations | — | 03026 | |
| 24 Mar 2026, 17:32 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 23 Mar 2026, 16:45 | Ceasing to be a substantial holder | Substantial Holders | — | 02003 | |
| 17 Mar 2026, 09:00 | Mayne Pharma to present at ASX SMIDcaps Conference | Presentations | — | 12008, 14014 | |
| 11 Mar 2026, 09:22 | DistributeRx Launch Investor Presentation | Presentations | — | 03026, 14014 |
1–50 of 129
1 / 3